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ABSTRACT Metazoans were proposed to host bacteriophages on their mucosal sur-
faces in a symbiotic relationship, where phages provide an external immunity
against bacterial infections and the metazoans provide phages a medium for inter-
acting with bacteria. However, scarce empirical evidence and model systems have
left the phage-mucus interaction poorly understood. Here, we show that phages
bind both to porcine mucus and to rainbow trout (Oncorhynchus mykiss) primary
mucus, persist up to 7 days in the mucosa, and provide protection against Flavobac-
terium columnare. Also, exposure to mucus changes the bacterial phenotype by in-
creasing bacterial virulence and susceptibility to phage infections. This trade-off in
bacterial virulence reveals ecological benefit of maintaining phages in the metazoan
mucosal surfaces. Tests using other phage-bacterium pairs suggest that phage bind-
ing to mucus may be widespread in the biosphere, indicating its importance for dis-
ease, ecology, and evolution. This phenomenon may have significant potential to be
exploited in preventive phage therapy.
IMPORTANCE The mucosal surfaces of animals are habitat for microbes, including
viruses. Bacteriophages—viruses that infect bacteria—were shown to be able to
bind to mucus. This may result in a symbiotic relationship in which phages find bac-
terial hosts to infect, protecting the mucus-producing animal from bacterial infec-
tions in the process. Here, we studied phage binding on mucus and the effect of
mucin on phage-bacterium interactions. The significance of our research is in show-
ing that phage adhesion to mucus results in preventive protection against bacterial
infections, which will serve as basis for the development of prophylactic phage ther-
apy approaches. Besides, we also reveal that exposure to mucus upregulates bacte-
rial virulence and that this is exploited by phages for infection, adding one addi-
tional layer to the metazoan-bacterium-phage biological interactions and ecology.
This phenomenon might be widespread in the biosphere and thus crucial for under-
standing mucosal diseases, their outcome and treatment.
KEYWORDS bacterial virulence, bacteriophage therapy, bacteriophages, host-
pathogen interactions, mucosal pathogens
Mucus is an essential component of the innate immune system, serving as aselective barrier between metazoans and their environments (1). It is a complex,
viscoelastic secretion that, in addition to protecting the host, provides a habitat for
countless microbes from all three domains of life, as well as viruses. Mucins, the main
components of the mucosal matrix, form a polymer-based hydrogel with lubricant and
protective properties. The mucin concentration of the mucus affects the mesh size of
the matrix, which controls diffusion through it and provides a first line of defense
against pathogens (2). Most infections start from the mucosal surfaces, and with over
200 known microorganisms capable of invading the mucus layers, mucosal infections
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result in mortality and morbidity, exhibiting clinical and economical importance world-
wide (3, 4).
Considering the heterogeneous composition of mucosal surfaces, there is a signif-
icant gap in knowledge on how its components influence mucosal infections. Previous
research has mainly focused on the pathogen, the host immune response in vitro, or the
effect of the commensal microbiome for mucosal homeostasis (5–7). Moreover, in 2013,
another layer of complexity was added to the already convoluted system when the
bacteriophage adherence to mucus (BAM) model was proposed (8). This model, based
on indirect evidence and in vitro testing, proposes an important and so far overlooked
symbiosis between metazoans and bacteriophages (phages): Phages would concen-
trate on mucosal surfaces by weak interactions with mucins, creating a ubiquitous
non-host-derived immunity against bacterial invaders during the mucus colonization
process. Phage structural proteins possessing Ig-like folds were proposed to be medi-
ators for phage interaction with mucins. A bioinformatic analysis of 246 double-
stranded DNA tailed-phage genomes revealed that roughly 25% have proteins with
Ig-like folds, all related to the viral structure (9). Indeed, the virus abundance in the
surface mucus layer of eels has been shown to be higher than that in surrounding
water; the subdiffusive motion of phages on mucus has been better understood; and
the spatial structuring of mucosal surfaces has been speculated to have a role in phage
replication strategies (10–12). However, the relevance of phage interaction with meta-
zoan mucus for bacterial infections has not been shown in a natural infection model.
Despite the obvious relevance to host-pathogen interactions and ecology, empirical
studies exploring the BAM hypothesis have remained scarce. Fish are naturally covered
by mucus layers and thus are excellent model organisms for studying phage-mucus
interactions and their consequent influences on bacterial infections, especially those
that affect mucosal surfaces. Flavobacterium columnare (phylum Bacteroidetes, family
Flavobacteriaceae), the causative agent of columnaris disease, is a major epidermal
pathogen in freshwater aquaculture worldwide and responsible for annual losses in the
magnitude of millions of dollars (13, 14). Previous studies have indicated that mucus
has a positive effect on F. columnare growth and virulence-related traits, suggesting
that interaction with the mucosal surfaces is important for the bacterial pathogenesis
(15–19). Furthermore, as treatment of columnaris disease is based on antibiotics, more
information on phages as tools to prevent bacterial infections is needed to reduce
antibiotic leakage into the environment (20). While phage therapy seems a promising
option against this (21) and many other diseases, detailed information on the interac-
tions of phages and their host bacteria in the mucosal environment is needed.
Here, we test phage adhesion to metazoan mucus and the consequent changes in
bacterial disease. Our data provide novel evidence on phage adherence to mucus in a
natural setting and possible trade-offs related to mucin-elicited changes in bacterial
virulence and phage susceptibility. Due to peculiarities concerning biological interac-
tions, growing F. columnare phages in liquid has always been difficult. Exposure of the
hosts to mucin made phage growth in liquid possible, facilitating large-scale produc-
tion of these phages and improving phage isolations. Phage-mucus interactions open
promising possibilities for the development of preventive phage therapy approaches
for mucosal diseases caused by bacteria in farmed animals and humans.
RESULTS
Ig-like domains in phage structural proteins support the suggestion of inter-
action mechanisms with mucus. To find a relevant system for studying the interaction
between phages, bacteria, and metazoans, we tested the ability of different phages to
bind to mucin-containing agar plates. Phage FCL-2 bound preferentially to mucin
plates (P  0.000001; F. columnare host), as did T4 (P  0.000005; Escherichia coli host),
V46 (P  0.001; Aeromonas sp. strain B135 host), FL-1 (P  0.001, Flavobacterium sp.
host), and PRD1 (P  0.01, Salmonella enterica host), while FLiP (Flavobacterium sp. host)
did not (see Fig. S1 in the supplemental material). Except for PRD1, all the mucin-
binding viruses were tailed phages with proteins containing putative Ig-like domains.
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Next, we confirmed the presence of Ig-like domains in the mucin-binding phages by
bioinformatics. In silico reannotation of the FCL-2 (21) genome using HHPred revealed
one open reading frame (ORF17: length, 114 amino acids; accession no. YP_009140518)
homologous to an N-terminal domain of orf48 in Lactococcus phage TP901-1 (proba-
bility, 98.94; E value, 4.5E10), which has been experimentally shown to encode a
baseplate protein with an Ig fold (22). The same result was achieved using Phyre2 for
homology detection (confidence, 86.5%; coverage, 53%). In the FCL-2 genome, ORF17
(bearing the Ig fold) is located between a putative peptidase and two hypothetical
proteins that are then followed by a putative portal protein and capsid proteins. This
suggests a structural function for this protein.
The genome sequencing of Aeromonas sp. podovirus V46 revealed a putative capsid
protein (accession no. MK733234) that was highly similar to phage P22 (HHPred:
probability, 100; E value, 1.7E62), including the telokin-like Ig domain. In addition, the
Phyre2 homology recognition resulted in 100% confidence (86% coverage) on the
probability that these sequences are homologous. No apparent Ig-like domains were
detected in Flavobacterium sp. phage FL-1, although a very weak hit to the same
N-terminal domain of orf48 in Lactococcus phage TP901-1 (probability, 53.25; E value,
100) as in FCL-2 was received.
The two Flavobacterium psychrophilum phages used in the study did not show
apparent homology to Ig-like folds in their predicted ORFs, and neither did the
structural proteins of the two tailless phages used, FLiP and PRD1.
The skin mucosa of rainbow trout retains phages for 1 week. Myophage FCL-2,
capable of infecting F. columnare, was chosen as model for further studies. This phage
is well characterized, possess Ig-like domains, and binds to mucins in vitro. To verify
phage FCL-2 retention by primary mucus in vivo, we exposed individual rainbow trout
to the phage and kept the fish in flowthrough aquaria. The daily phage titers, in PFU
ml1, were measured from the water and fish skin mucus. Phage titers in water
decreased rapidly, and at some time points, no phages were detected. However,
phages were found on the mucus consistently for up to 7 days after phage exposure,
despite the water flow and mucus shedding (Fig. 1). No phages were detected on water
or mucus 15 days after exposure (data not shown).
Pretreatment with phage protects fish from disease. To test if phage retention by
mucus is relevant for protection against disease, we exposed rainbow trout to a single
dose of FCL-2 phage for 1, 3 or 7 days before exposure to F. columnare. To study the
influence of a co-occurring phage on FCL-2 mucus adhesion and fish protection, we
also exposed the fish to a mixture of FCL-2 and T4 for 1 or 7 days before infection. T4
also contains Ig-like domains and has been shown to bind to mucin, but is not able to
infect F. columnare. FCL-2 maintained its presence in the mucus of fish from all the
preexposed groups, but was found in the water only when exposure occurred 1 or
3 days before infection (Fig. 2A and B). T4 was present in mucus in fish exposed for 1
FIG 1 Phages persist on the rainbow trout skin mucosa for up to 1 week after a single exposure. Shown
are phage FCL-2 titers in water (gray open circles) and fish mucus (black triangles) over time in a
flowthrough aquarium. Fish were exposed to the phage only once, at time zero, and water flow was
opened after 3.5 h. Each data point represents the average from three individual fish or three indepen-
dent water samples and their standard deviation.
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and 7 days, but only recovered from the water when exposure occurred 1 day before
infection (Fig. 2B). The T4 presence did not affect FCL-2 adhesion to mucus, and both
phages were recovered at similar titers from the fish.
Exposing the fish to FCL-2 alone or FCL-2 mixed with T4 before the F. columnare
challenge resulted in a delay in the disease onset and increased fish survival. Fish
FIG 2 Phage retention on mucus allows for the prophylactic use of phages against bacterial infections. Fish were pretreated with FCL-2 alone (1, 3 or 7 days)
or with FCL-2 and T4 (1 or 7 days) before infection with Flavobacterium columnare. (A) FCL-2 phage titers in fish mucus and aquarium water (before infection)
from FCL-2-only groups. (B) FCL-2 and T4 titers from fish mucus and aquarium water (before infection) in the combined FCL-2 and T4 groups. (C) Fish survival
in the FCL-2-only-pretreated groups. (D) Fish survival in the combined FCL-2- and T4-pretreated groups. (E) FCL-2 titers in water after infection in the FCL-2-only
groups. (F) FCL-2 and T4 titers in water after infection in the combined FCL-2 and T4 groups. (G) F. columnare quantity (genomic copies) in water after infection
in the FCL-2-only-pretreated groups. (H) F. columnare quantity (genomic copies) in water after infection in the combined FCL-2- and T4-pretreated groups. Each
data point represents one individual fish or water sample and the standard deviations in panels A and B. In panels C and D, the number of fishes used was
15 per group, except in the negative control (n  16) and the group exposed to FCL-2 alone for 7 days (n  12). In panels E, F, G, and H, the data points represent
the average of triplicates and their standard deviation. The log-rank (Mantel-Cox) test was used for evaluation of the survival curves in panels C and D. Unpaired
t tests were used to compare the controls and tested conditions in panels G and H (*, P  0.05; **, P  0.001).
Almeida et al. ®
November/December 2019 Volume 10 Issue 6 e01984-19 mbio.asm.org 4






































pretreated with FCL-2 alone for 1 and 3 days survived longer than controls (P values of
0.0398 and 0.0013, respectively [Fig. 2C]). When combined with T4, FCL-2 could protect
fish in the 1- and 7-day pretreatment groups (P  0.0001 and 0.0003, respectively
[Fig. 2D]). Interestingly, the presence of T4 enhanced the protective effect of FCL-2, as
fish exposed 7 days before infection to both phages had higher survival rates than fish
exposed only to FCL-2 in the same time frame (P  0.0008).
The FCL-2 titers in the water increased over time, peaking around 35 h after
exposure to F. columnare, indicating successful replication (Fig. 2E and F). T4 did not
replicate in this system. Furthermore, the abundance of F. columnare genome copies
was measured by quantitative PCR (qPCR) and was inversely proportional to the FCL-2
titers (Fig. 2G and H). Compared with the controls, the reduction of bacterial genome
copies was significant at 35 h after infection in the groups pretreated with FCL-2 alone
at 1 and 3 days before infection (P  0.005 and 0.002, respectively) and groups pre-
treated with FCL-2 and T4 at 1 and 7 days before infection (P  0.004 and 0.009,
respectively).
Exposure to a simulated mucosal environment influences bacterial virulence. In
cultures containing mucin as a supplement, F. columnare formed a thick biofilm ring on
the liquid-air interface and smaller biofilm strings spread over the tube walls (Fig. 3A
and B). Details of the biofilm structure can be seen in Fig. S2A to C in the supplemental
material. Mucin exposure resulted in positive chemotaxis, larger colony size and
improved protease secretion after mucin exposure (Fig. S2D to F).
An infection experiment revealed that exposure to mucin increased bacterial viru-
lence in vivo. A lower dose of F. columnare grown in mucin (11.8 times fewer cells) had
the same virulence as a higher dose of cells from control cultures (P  0.3137 [Fig. 3C,
black and gray lines]). In addition, the cells from mucin cultures killed fish more
efficiently than a 2.3 times higher dose from control cultures (P  0.0314 [Fig. 3C, black
and blue lines]). The survival of fish exposed to control cells was dose dependent
(P  0.0285 [Fig. 3C, gray and blue lines]).
Exposure to primary mucus and purified mucin makes bacteria susceptible to
phage infection. Since mucin exposure changes the F. columnare phenotypic charac-
teristics, we next studied whether the presence of mucin or mucus affects bacterial
susceptibility to phage infections. F. columnare strain B185 grown under control
conditions or with primary fish mucus or purified porcine mucin was infected with
phage FCL-2. The culture aspect in primary mucus cultures was similar to that in
mucin-containing cultures (biofilm formation). While the phage yield was negative (i.e.,
no phage replication) in control cultures and cultures containing low mucus and mucin
concentrations, it was hundreds- to thousands fold higher than the initial inoculum at
the higher concentrations (Fig. 4A and B). Compared with controls, a significant
increase in phage titers was detected 24 and 48 h after infection in media containing
13.25 mg ml1 of mucus (P  0.0001), 0.1% mucin (P  0.008 and 0.00003, respec-
tively), and 1% mucin (P  0.007 and 0.00001, respectively).
FIG 3 Exposure to mucin increases Flavobacterium columnare virulence. Macroscopic view of a 22-h-old culture of F. columnare in 0.5 Shieh medium (A) or
in 0.5 Shieh medium supplemented with 0.1% mucin (B). Note the thick biofilm ring on the liquid-air interface, biofilm strings, and clearer supernatant. (C)
Fish survival from a virulence test in vivo comparing F. columnare grown in 0.5 Shieh medium to F. columnare grown in 0.5 Shieh medium supplemented
with 0.1% mucin. In panel C, the total number of fishes used was 15 per group, except for the group treated with mucin at 1.83  105 PFU/ml (n  14). The
log-rank (Mantel-Cox) test was used to evaluate survival curves in panel C (*, P  0.05).
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Fast biofilm formation and strong biofilm structure make the titration of F. co-
lumnare cells grown in mucin difficult, so we opted for not quantifying the host cells to
avoid misleading comparisons between culture conditions. However, by testing the
supernatant of mucin cultures, we were able to determine that phage replication
happens in planktonic cells (see Fig. S3A in the supplemental material), and phage
presence is able to limit biofilm spread (Fig. S3B). Morphological changes in colony type
lasted longer than susceptibility to phages after mucin exposure (see Fig. S4A to C in
the supplemental material). Phage FCL-2 growth on other F. columnare strains was also
favored by mucin exposure, as was growth of other F. columnare phages from our
collection (see Fig. S5A and B in the supplemental material).
Changes in bacterial physiology elicited by mucin exposure and the conse-
quent improved phage growth are not limited to F. columnare. After verifying that
mucin exposure changes F. columnare virulence and affects phage growth, we tested
other bacterial species (see Fig. S6A to F in the supplemental material) to determine the
generality of our finding. Cultures supplemented with mucin led to the formation of
biofilm in Aeromonas sp. strains (B135 and B158), suggesting that mucin exposure also
modifies the physiology of these bacteria. Indeed, primary fish mucus made Aeromonas
sp. strain B135 more susceptible to infection by phage V46 (P  0.03 at 24 h and
P  0.000002 at 48 h [Fig. 5A]). Although no significant effect was initially seen in the
purified porcine mucin cultures (Fig. 5B), changing the timing of mucin exposure
from preexposure to adding mucin at the time of infection also resulted in improved
phage production (P  0.03 at 24 h and P  0.00006 at 48 h [Fig. 5C]). A clear pattern
of higher phage V61 production in Aeromonas sp. strain B158 cells exposed to mucin
was observed, but phage quantification was not possible due to difficulties in counting
the plaques. These data suggest that mucin-mediated changes in the phage-bacterium
interaction may be widespread in nature among bacterial species that infect or live on
mucosal surfaces.
DISCUSSION
Inspired by the BAM model proposed by Barr et al. (8) and using a natural infection
system (rainbow trout, its bacterial pathogen F. columnare, and the phage FCL-2), we
studied how the mucus environment affects phage-bacterium interactions. We show
that several phages bind to mucin, and an F. columnare-infecting phage binds to
primary fish mucus and purified porcine mucin at comparable levels to those of phage
T4. This led us to test the role of phage binding on phage-bacterium interactions and
infection in a fish host.
The interaction between mucus and phages has been suggested to occur between
Ig-like domains in the phage capsid and glycan residues from mucin molecules. The
ORFs in FCL-2 do not show any similarity to the highly antigenic outer capsid protein
(hoc) of T4, which mediates adherence to mucus (8). However, FCL-2 ORF17 has
homology with a phage protein possessing an Ig-like fold, the lactococcal phage
FIG 4 Exposure to simulated mucosal environments makes Flavobacterium columnare susceptible to phage infection. (A) FCL-2 titers over time on 0.5 Shieh
cultures supplemented with primary rainbow trout mucus. (B) FCL-2 titers over time on 0.5 Shieh cultures supplemented with purified porcine mucin. Each
data point represents the average of triplicates and their standard deviation. Unpaired t tests were used to compare the controls and tested conditions (*,
P  0.05; **, P  0.001).
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TP901-1 baseplate wedge protein. This implies that the mechanisms for persisting in
the mucus for T4 and FCL-2 may be similar. In addition, the Aeromonas sp. podovirus
V46, which was also enriched in mucin-containing plates, has a highly similar capsid
protein to that of phage P22, and both phages possess the telokin-like Ig domain in the
capsid protein. The mucus-binding mechanism of phage FL-1 remains speculative.
Some of the structural proteins and especially putative tail proteins of FL-1 and FCL-2
are similar, and it is possible that the ORF in FL-1 (length, 134 amino acids; accession
no. APZ82894), located between putative capsid and tail genes, has the same function
despite clear sequence similarity. The mucin-binding mechanism of the coliphage
PRD1, a type of member of the Tectiviridae, remains unclear because they do not have
distinct Ig-like folds in their structural proteins.
Phage concentrations remained relatively high in the rainbow trout mucus for 1 to
3 days after exposure, providing protection against bacterial infection. A significant
delay in the onset of disease and increase in fish survival was obtained, although
complete protection was not seen. It is important to note that the experimental
conditions with the high dose of bacteria used favored the bacterial infection and not
the phage. Interestingly, our results also imply that the co-occurrence with “nonrel-
evant” phages may influence phage-bacterium interactions in the mucus. Our data
suggest that preexposure to FCL-2 combined with T4 protects fish longer than FCL-2
alone, although T4 did not replicate in the system. The mechanism behind this finding
is still not known, but since the T4 particle is larger than that of FCL-2, it may help in
keeping FCL-2 in the lower mucus layer. More studies are needed to understand how
mucus influences the interactions between phages and how combinations of different
phages (phage cocktails) may influence protection against infection.
Our results demonstrate that the prophylactic use of phages in phage therapy can
be relevant and effective. Exposing metazoans to phages as prophylaxis against
bacterial infections has been tested in the past. In 2017, a cocktail of three phages
against Vibrio cholerae was shown to be effective if given orally 24 h before infecting
mice and rabbits, and phage retention on the intestine was shown (23). In another
study, a phage infecting Salmonella enterica serovar Enteritidis was more efficient in
FIG 5 Exposure to simulated mucosal environments makes Aeromonas sp. strain B135 susceptible to phage V46. (A) V46 titers over time on 0.2 LB cultures
supplemented with primary rainbow trout mucus. (B) V46 titers over time on 0.2 LB cultures supplemented with purified porcine mucin. For panels A and
B, the bacteria were grown in mucus or mucin 20 h before infection with phages. (C) V46 titers over time on 0.2 LB cultures supplemented with purified
porcine mucin at the time of infection. Each data point represents the average of triplicates and their standard deviation. Unpaired t tests were used to compare
controls and tested conditions (*, P  0.05; **, P  0.001).
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protecting poultry if given prophylactically by an oral route. Phages were recovered
from feces 7 days after treatment, even in the group not challenged with the bacterial
host (24). Furthermore, massive human trials based on preventive phage therapy
(called “prophylactic phaging”) were performed in the past by the former Soviet Union.
Phage pretreatment reduced disease occurrence, and phage persistence for days in the
human body was recorded (25). Although the exact mechanism of phage retention was
not studied, it is possible that the success of prophylactic use of phages, under
experimental conditions and in human trials, is mediated at least in part by phage
subdiffusion on mucosal surfaces. Subdiffusive motion in mucus would hold phages in
the mucosa, allowing the phages to find and infect invading mucosal pathogens. A
recent finding suggesting mucus layers may negatively affect antibiotic activity on
Pseudomonas aeruginosa (26) highlights the potential of phages in protecting against
mucosal infections.
In addition to phage retention by mucus, we investigated bacterium and phage
interactions on simulated mucosal environments. Culture media containing primary
mucus from rainbow trout or purified porcine mucin affected bacterial phenotypic
characteristics (see also references 27 and 28) and susceptibility to phage infection.
Interestingly, exposure to mucin directly increased bacterial virulence, most likely due
to the close relationship of F. columnare with its host mucus, demonstrated by the
characteristics of the epidermal symptoms of the disease. As such, upregulation of
bacterial virulence via mucin exposure may also be relevant for other bacteria, as
indicated by two Aeromonas sp. strains that form biofilm as a response to primary
mucus or mucin. In addition, it has been described that mucin exposure increases the
mucus-binding capacity of Lactobacillus reuteri strains, and in this case, mucin may be
acting as a signal that changes cell transcriptional status (29).
Furthermore, our results suggest that the mucin-induced upregulation of bacterial
virulence has trade-offs in making bacteria more susceptible to phage infection. These
data add another component to the bacteria-mucus interaction and the BAM model by
suggesting more direct evolutionary benefits of phage binging on mucus by increasing
the costs of bacterial virulence. At the molecular level, phages may have evolved to
exploit the upregulation of bacterial virulence factors in the mucus environment. This
emphasizes the ecological relevance of microbial interactions in the eukaryotic mucus
environments, with implications for the outcome of disease. In the case of F. columnare,
one possible mechanism could be the expression of gliding motility in the presence of
mucus. Flavobacterial gliding motility is linked with the type IX secretion system of
virulence factors (30), and loss of gliding motility has been associated with a decrease
in bacterial virulence and linked with phage resistance for F. columnare (31). Indeed, in
our study, mucin increased both bacterial colony spreading (indicating increased
gliding motility) and secretion of proteases. Increase in motility may increase the
availability of surface receptors for phage infections. This is supported by our findings
regarding upregulation of bacterial motility by mucin and also by the fact that phages
grows preferentially in F. columnare planktonic cells. Nevertheless, the mucus-induced
changes in bacterial phage susceptibility enabled us to overcome the decades-old
difficulties regarding production of F. columnare phages in liquid cultures (32). This
opens possibilities for isolating new F. columnare-associated viruses and growing them
for large-scale purposes.
Mucus may have a significant effect for phage– bacterium interactions on a wider
scale. A study focusing on Clostridium difficile and phage interaction on human cell
cultures concluded that the phage more efficiently reduces the number of planktonic
and adherent bacterial cells in the presence of the human cells than occurs in vitro (33).
Although this suggests that increased phage activity was related to strong phage
adsorption to the cells, no data were presented regarding human cells’ effect on the
bacterium. The HT-29 cells used are known to be heterogeneous, containing a small
percentage of mucin-secreting cells, and HeLa cells produces at least MUC1 (34, 35), so
the possibility exists that the released cell-derived mucus changes the bacterial phys-
iology and increases its susceptibility to phages. When testing our collection of
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freshwater bacteria, we found two Aeromonas sp. strains that behaved similarly to F.
columnare in terms of biofilm formation and phage susceptibility after primary mucus
and purified mucin exposure. Although no virulence data exist for these isolates, the
Aeromonas genus contains many putative disease-causing species (36); thus, interaction
with metazoan mucus may also play an important role for these organisms and its
interaction with phages.
Our data confirm that phage binding to mucosal surfaces is important for protection
against disease. Preferential binding to mucosal surfaces by both bacterial pathogens
and their phages suggests that deeper investigation of phage-bacterium interactions in
mucus is relevant for understanding mucosal pathogens. This approach provides
important mechanistic information on the use of phages for prevention of bacterial
diseases and highlights the relevance of the use of “phaging” in future phage therapy
trials. Preventive enrichment of the metazoan mucus layers with phages would allow
modulation of the host microbiome, thereby generating a protective phage layer that
could help to avoid disease. Thus, a prophylactic phage therapy approach could
improve the health of farmed animals and also humans. In conclusion, our study has
implications that can be applied to provide deeper understanding of the phage-
bacterium interactions on metazoan mucosal surfaces on a broader scale.
MATERIALS AND METHODS
Bacteria and phages. The bacterial strains and phages used in this study are listed in Table S1 in the
supplemental material. F. columnare strain B185 and its phage FCL-2 (myophage) were chosen as models
because they have been well characterized and shown to be relevant for phage therapy studies (21). The
other strains were used for validation of our observations. Phage lysates were filtered through 0.22-m-
pore filters to obtain cell-free lysates.
Growth conditions, phage titrations, primary mucus, and mucin preparation. F. columnare,
Flavobacterium johnsoniae, Chryseobacterium indologenes and Flavobacterium sp. strains were cultured in
modified Shieh medium (without glucose, as described by Song et al. [37]) at 25°C and 120 rpm. F.
psychrophilum was cultivated in TYES medium (38) at 15°C and 120 rpm. E. coli and S. enterica were
cultivated in LB medium at 37°C and 200 rpm. Aeromonas salmonicida, Aeromonas sp. strains, Pseudomo-
nas fluorescens, and Yersinia ruckeri were cultivated in 0.2 LB medium at 25°C and 120 rpm. The phages
were titrated using the double-layer agar method on the appropriate hosts (39). Bacterial inocula were
normalized by adjusting the optical density at 595 nm (OD595) from overnight cultures. In the case of F.
columnare, a regression curve was used for estimating CFU (CFU from OD values to calculate the inocula
and multiplicity of infection [MOI] whenever necessary).
Primary mucus was collected from rainbow trout individuals (Oncorhynchus mykiss) for use in
simulated mucosal cultures. Fish (mean size of 8 cm) were euthanized with an overdose of benzocaine,
and primary mucus was harvested by scraping the skin with a glass slide. Mucus was pooled on Falcon
tubes on ice and briefly centrifuged (1,000  g, 5 min, 4°C) to remove scales and other debris, and then
the supernatant was autoclaved and the sterile mucus was aliquoted and stored at –20°C until use. The
total protein concentration was determined by nanodrop measurements. As an example, a batch made
from 277 fish yielded around 100 ml of primary mucus with a total protein concentration of 26.5 mg/ml.
Alternatively, purified porcine mucin (Sigma, catalog no. M1778) was diluted in water to a 2% final
concentration, autoclaved, and stored at 4°C. The total protein concentration of a 2% mucin solution
varied from 20 to 26 mg/ml, depending on the batch.
Simulated mucosal cultures were prepared by mixing complete culture media to an equal volume of
primary mucus or purified porcine mucin and water, resulting in 0.5 medium containing the desired
amount of mucus or mucin. These cultures were made to test how mucin or primary mucus presence
would affect biological interactions between phages and bacteria. Doses of 0.1325, 1.325, and 13.25 mg
ml1 of primary mucus were used, which corresponded to the total protein concentration of 0.01, 0.1,
and 1% purified mucin solutions, respectively. Controls consisted of 0.5 media. Optimal results for F.
columnare were obtained by inoculating 5 ml of medium with 5  104 CFU and then infecting the
cultures 22 h later with phages (MOI of 0.01, estimated from the control bacterial number).
Identification of the Ig-like domain in phage genomes. The genome of phage FCL-2 has been
sequenced (21). Here, the genome was reannotated (September 2018) using protein BLAST (40) and
HHPred (41, 42) for protein homology detection and structure prediction. HHPred was also utilized for
analyzing ORFs from F. psychrophilum phages FpV-4 and FpV-8, Salmonella phage PRD1, and the capsid
protein of Aeromonas sp. phage V46. In addition, Phyre2 (43) was used for protein fold recognition of
predicted structural proteins. Sequences used for the analysis are listed in Table S2 in the supplemental
material.
Phage retention by rainbow trout skin mucus. To test phage retention in mucosal layers, 30 fish
(mean size, 8  0.96 cm) were incubated with 1.25  1012 PFU of FCL-2 in 2 liters of water (6.25  108
PFU ml1) for 30 min. Then, 4 liters of freshwater was added into the aquarium. Three hours later, the
water flow was opened, resulting in a change of water at a rate of 860 ml min1 over the duration of the
experiment. Aerated water was maintained at 15°C, and the fish were fed daily. At the indicated time
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points, three fish were collected from the aquarium and euthanized with benzocaine; their skin mucus
was scraped with the help of a glass slide and mixed with 450 l of Shieh medium. Three independent
water samples (450 l each) were also collected. All the samples were preserved by the addition of
chloroform (10% final concentration) and used later for phage titrations.
Prophylactic phage therapy experiment. The protective effect of phage retention in fish skin
mucus was tested. One week before the experiment, 118 rainbow trout (mean size, 8.3  1.12 cm) were
moved from the stock tanks to experimental aquaria and acclimatized to 25°C (an increment of 2°C per
day, except on the first and last days). At 7 days, 3 days, and 1 day before the infection, designated
groups of fishes were exposed to phages. Exposure was made by moving the fish to 4 liters of water
containing 1  1012 PFU of FCL-2 (2.5  108 PFU ml1) alone or a mixture of 1  1012 PFU of FCL-2 and
1.2  1012 PFU of T4 in 4 liters of water (2.5  108 and 3  108 PFU ml1, respectively). One aquarium was
used for each condition: five for the phage pretreatments and two for controls (fishes not exposed to
phages). After 30 min of exposure to phages, the water flow was opened (water flow was 248  35 ml/
min). The fish were fed daily until the time of infection and kept in aerated water during all of the
experiments.
On the day of infection, the fish were moved to aquaria containing 2 liters of water (each of the seven
original aquaria was divided into three aquaria with five fish in each), with no flowthrough. Before the
fish were transferred from the phage-treated groups, they were immersed in freshwater to minimize
the carryover of phages not attached to the mucus. Then, the bacteria were added to these aquaria for
the bacterial immersion challenge (see below), and 2 h later, the fish were moved to larger aquaria
containing 6 liters of freshwater (no flowthrough, divisions of three aquaria per tested condition kept).
The fish were checked regularly, and dead or moribund fish were removed from the aquaria.
The bacterial inoculum was prepared by adding 2  106 CFU of F. columnare strain B185 to 200 ml
of Shieh medium (triplicates). Twenty-four hours later, at the time of infection, the bacterial number was
estimated by OD measurements and confirmed by titrations. The density of bacteria used for infections
was 9.96  108 PFU per aquarium (4.98  105 CFU ml1 in the 2 liters used for the immersion challenge).
The mucus of three fish from each condition tested (phage pretreatments and controls) was collected
before the infection process. Water from the original aquaria (where the fishes and phages were kept)
was also collected at the same time. At 10, 20, 34, and 48 h after infection, water from all the aquaria was
collected. All the samples were preserved by the addition of chloroform to a final concentration of 10%
and used for phage titrations and qPCR.
Virulence in vivo. The effect of mucin exposure to bacterial virulence was tested in an experimental
setting similar to that of the prophylactic testing described above but using 59 fish (mean size,
8.08  1.17 cm) and no phage treatments. The bacterial inoculum was prepared by adding 2  106 CFU
of F. columnare strain B185 to control cultures (0.5 Shieh) or 0.5 Shieh supplemented with 0.1% mucin
cultures 1 day before the infection. For each condition, three individual 200-ml cultures were prepared.
Twenty-four hours later, at the time of infection, the bacterial number was estimated by OD measure-
ments and confirmed by titrations. In the case of mucin cultures, only the supernatant (containing
planktonic cells) was used, and the biofilms were discarded. The doses used for infection were 2.17  106
and 4.22  105 CFU ml1 for controls and 1.83  105 CFU ml1 for mucin-grown bacteria in the 2 liters
of the immersion challenge. The fish were monitored frequently for disease symptoms and morbidity.
Morbid fish that did not respond to external stimuli were considered dead and removed from the
experiment.
Quantitative PCR. To quantify the F. columnare genome copies from aquarium water, a quantitative
PCR was designed to detect the CRISPR spacer region in strain B185. The reactions were performed with
5 l of water samples as the template, 0.3 M forward (ATTTGGCGGTTGACCATAGAT) and reverse
(CGGTGTCCACTTGAAATACCTTAC) primers, and 10 l of 2 SYBR green Supermix (iQ SYBR green
Supermix, Bio-Rad) in a 20-l reaction volume. All the samples were amplified in triplicate. The PCR
started at 95°C for 3 min for initial denaturation, followed by 40 cycles of 15 s at 95°C for denaturation
and 60 s at 60°C for annealing. High-resolution melting analysis was performed immediately afterwards
by increasing the temperature from 55°C to 95°C by steps of 0.5°C maintained for 5 s each. A standard
curve for the quantification of B185 was generated by analyzing a 10-fold dilution series of its DNA with
known quantities of 5 ng l1 to 0.005 pg l1 1 (equivalent to 2  106 to 2 copies).
Statistical analysis. Analysis was done using the GraphPad software version 8.0.1. The log-rank
(Mantel-Cox) test was used for evaluation of the survival curves. Unpaired t tests were employed for
comparison of controls and tested conditions in the appropriate data sets.
Animal experimentation. Fish experiments were conducted according to the Finnish Act on the Use
of Animals for Experimental Purposes, under permission ESAVI/3940/04.10.07/2015 granted for Lotta-
Riina Sundberg by the National Animal Experiment Board at the Regional State Administrative Agency
for Southern Finland.
Data availability. The data supporting the findings of this study are available within this article and
the supplemental material (44–46).
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